Increased risks of deep vein thrombosis and pulmonary embolism in sjögren syndrome: A nationwide cohort study

Journal of Rheumatology

Volumn 41, Issue 5, 2014, Pages 909-915

  Chung, Wei Sheng ^a   Lin, Cheng Li ^e   Sung, Fung Chang ^b   Hsu, Wu Huei ^c   Chen, Yung Fu ^f   Kao, Chia Hung ^d  

^a CHINA MEDICAL UNIVERSITY   (China)

^b China Medical University Hospital   (China)

^c College of Medicine   (United Kingdom)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e China Medical University Hospital   (China)

^f CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Deep vein thrombosis; Pulmonary embolism; Sj gren syndrome

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SJOEGREN SYNDROME; TAIWAN; AGEISM; INCIDENCE; LONGITUDINAL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; RISK FACTOR; SEXISM; SJOGREN'S SYNDROME; VENOUS THROMBOSIS;

AGED; AGEISM; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SEXISM; SJOGREN'S SYNDROME; TAIWAN; VENOUS THROMBOSIS;

EID: 84899738430     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131345     Document Type: Article

References (36)

1. Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology 2006;45 Suppl 3:iii3-4 (Pubitemid 44446764)
2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8 (Pubitemid 34539104)
3. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:I4-8
4. Noel P, Gregoire F, Capon A, Lehert P. Atrial fibrillation as a risk factor for deep venous thrombosis and pulmonary emboli in stroke patients. Stroke 1991;22:760-2
5. Becattini C, Vedovati MC, Agnelli G. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. Thromb Res 2012;129:392-400
6. Bembenek J, Karlinski M, Kobayashi A, Czlonkowska A. Early stroke-related deep venous thrombosis: risk factors and influence on outcome. J Thromb Thrombolysis 2011;32:96-102
7. Stein PD, Goldman J, Matta F, Yaekoub AY. Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci 2009;337:259-64
8. Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with diabetes mellitus. Am J Med 2012;125:709-16
9. Dean SM, Abraham W. Venous thromboembolic disease in congestive heart failure. Congest Heart Fail 2010;16:164-9
10. Tien WC, Kao HY, Tu YK, Chiu HC, Lee KT, Shi HY. A population-based study of prevalence and hospital charges in total hip and knee replacement. Int Orthop 2009;33:949-54
11. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141 Suppl 2:e278S-325S
12. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005;6:401-10 (Pubitemid 40753746)
13. Yu YB, Gau JP, Liu CY, Yang MH, Chiang SC, Hsu HC, et al. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost 2012; 108:225-35
14. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1
15. Zoller B, Li X, Sundquist J, Sundquist K. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis 2012;2:171-83
16. Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 2013 Aug 13 (E-pub ahead of print)
17. Porola P, Laine M, Virkki L, Poduval P, Konttinen YT. The influence of sex steroids on Sjogren's syndrome. Ann N Y Acad Sci 2007;1108:426-32 (Pubitemid 47528756)
18. Furness S, Bryan G, McMillan R, Birchenough S, Worthington HV. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev 2013;9:CD009603
19. Ng WF, Bowman SJ. Primary Sjogren's syndrome: too dry and too tired. Rheumatology 2010;49:844-53
20. Ng WF, Bowman SJ. Biological therapies in primary Sjogren's syndrome. Expert Opin Biol Ther 2011;11:921-36
21. Chung WS, Lin CL, Peng CL, Chen YF, Lu CC, Sung FC, et al. Rheumatoid arthritis and risk of acute myocardial infarction-A nationwide retrospective cohort study. Int J Cardiol 2013; 168:4750-4
22. Cheng TM. Taiwan's National Health Insurance system: high value for the dollar. In: Okma KGH, Crivelli L, eds. Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. New Jersey: World Scientific; 2009:71-204
23. Igoe A, Scofield RH. Autoimmunity and infection in Sjogren's syndrome. Curr Opin Rheumatol 2013;25:480-7
24. Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2012;379:244-9
25. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009;123 Suppl 4:S11-7
26. Keenan CR, White RH. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 2007;13:377-83 (Pubitemid 47472297)
27. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005;131:417-30 (Pubitemid 43899639)
28. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010;30:5-6, 8-9
29. Dahlback B. Coagulation and inflammation - close allies in health and disease. Semin Immunopathol 2012;34:1-3
30. Coiteux I, Mazzolai L. (Deep vein thrombosis: epidemiology, risk factors and natural history. In French). Praxis 2006;95:455-9
31. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861-6 (Pubitemid 24135768)
32. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ, et al. Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997;15:361-5 (Pubitemid 27323996)
33. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-53 (Pubitemid 29178795)
34. Haga HJ, Jacobsen EM, Peen E. Incidence of thromboembolic events in patients with primary Sjogren's syndrome. Scand J Rheumatol 2008;37:127-9 (Pubitemid 351536083)
35. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94 (Pubitemid 351173321)
36. Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD. High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost 2005;94:797-801. (Pubitemid 41489240)